Zomedica Book Value Per Share Growth & History (ZOMDF)
Zomedica's book value per share was $0.12 for fiscal 2025.
View full Zomedica company overviewZomedica annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.12 | -$0.08 | −41.02% |
| 2024 | 2024-12-31 | $0.20 | -$0.05 | −18.48% |
| 2023 | 2023-12-31 | $0.24 | -$0.03 | −10.24% |
| 2022 | 2022-12-31 | $0.27 | -$0.00 | −1.30% |
| 2021 | 2021-12-31 | $0.28 | $0.22 | +353.82% |
| 2020 | 2020-12-31 | $0.06 | $0.15 | — |
| 2019 | 2019-12-31 | -$0.09 | -$0.13 | — |
| 2018 | 2018-12-31 | $0.04 | -$0.01 | −22.94% |
| 2017 | 2017-12-31 | $0.05 | $0.00 | +6.47% |
| 2016 | 2016-12-31 | $0.05 | — | — |
Zomedica quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.11 | -$0.02 | −14.42% |
| Q1 2026 | 2026-03-31 | $0.11 | -$0.02 | −16.23% |
| Q4 2025 | 2025-12-31 | $0.12 | -$0.08 | −41.02% |
| Q3 2025 | 2025-09-30 | $0.12 | -$0.08 | −41.00% |
| Q2 2025 | 2025-06-30 | $0.13 | -$0.09 | −39.94% |
| Q1 2025 | 2025-03-31 | $0.14 | -$0.10 | −42.89% |
| Q4 2024 | 2024-12-31 | $0.20 | -$0.05 | −18.48% |
| Q3 2024 | 2024-09-30 | $0.21 | -$0.06 | −22.25% |
| Q2 2024 | 2024-06-30 | $0.21 | -$0.05 | −19.56% |
| Q1 2024 | 2024-03-31 | $0.24 | -$0.03 | −11.85% |
| Q4 2023 | 2023-12-31 | $0.24 | -$0.03 | −10.24% |
| Q3 2023 | 2023-09-30 | $0.27 | -$0.01 | −2.94% |
| Q2 2023 | 2023-06-30 | $0.26 | -$0.01 | −2.54% |
| Q1 2023 | 2023-03-31 | $0.27 | -$0.01 | −2.23% |
| Q4 2022 | 2022-12-31 | $0.27 | -$0.00 | −1.30% |
| Q3 2022 | 2022-09-30 | $0.27 | -$0.00 | −1.05% |
| Q2 2022 | 2022-06-30 | $0.27 | -$0.01 | −3.76% |
| Q1 2022 | 2022-03-31 | $0.27 | -$0.01 | −3.83% |
| Q4 2021 | 2021-12-31 | $0.28 | $0.22 | +353.82% |
| Q3 2021 | 2021-09-30 | $0.28 | $0.14 | +105.72% |
| Q2 2021 | 2021-06-30 | $0.28 | $0.23 | +478.51% |
| Q1 2021 | 2021-03-31 | $0.29 | $0.36 | — |
| Q4 2020 | 2020-12-31 | $0.06 | $0.15 | — |
| Q3 2020 | 2020-09-30 | $0.13 | $0.20 | — |
| Q2 2020 | 2020-06-30 | $0.05 | $0.09 | — |
| Q1 2020 | 2020-03-31 | -$0.08 | -$0.06 | — |
| Q4 2019 | 2019-12-31 | -$0.09 | -$0.13 | — |
| Q3 2019 | 2019-09-30 | -$0.06 | -$0.09 | — |
| Q2 2019 | 2019-06-30 | -$0.04 | -$0.09 | — |
| Q1 2019 | 2019-03-31 | -$0.02 | -$0.06 | — |
| Q4 2018 | 2018-12-31 | $0.04 | -$0.01 | −22.94% |
| Q3 2018 | 2018-09-30 | $0.03 | — | — |
| Q2 2018 | 2018-06-30 | $0.05 | — | — |
| Q1 2018 | 2018-03-31 | $0.04 | — | — |
| Q4 2017 | 2017-12-31 | $0.05 | $0.00 | +6.47% |
| Q4 2016 | 2016-12-31 | $0.05 | — | — |
Zomedica book value per share trends
Over the last five fiscal years, Zomedica's book value per share increased from $0.06 to $0.12, a change of $0.06. The latest reported quarter, Q2 2026, shows $0.11.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zomedica source filings ↗